awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36087899-B3B7D405-3A49-4A77-908D-EF7973D47F95
Q36087899-B3B7D405-3A49-4A77-908D-EF7973D47F95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36087899-B3B7D405-3A49-4A77-908D-EF7973D47F95
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer.
P2860
Q36087899-B3B7D405-3A49-4A77-908D-EF7973D47F95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36087899-B3B7D405-3A49-4A77-908D-EF7973D47F95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c49aaace42c0262e9603104114280914af5c5e6a
P2860
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.